$0.81
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+964.4% upside
Low Target
$6.90
Average Target
$8.60
High Target
$12.01
Current Price
$0.81
Current
$0.81
$0.81
Target
$8.60
$8.60
$6.90
$8.60 avg
$12.01
Scenario Analysis
Bear Case
$6.90
754.0%
Low target
Base Case
$8.60
+964.4%
Avg target
Bull Case
$12.01
+1,386.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.17
-91.2% from high
52-Week Low
$5.46
+-85.2% from low
Target vs 52W High
$8.60
-6.2% vs high
Next Earnings Report
Mar 2, 2026 · After Market Close
13d
until earnings
EPS Est: $-0.08
Earnings in 13 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 82% | $369.21 | -32.0% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -27.0% |
| A | Buy | 29 | 72% | $64.69 | -50.1% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -55.8% |
| MTD | Hold | 21 | 43% | $170.43 | -87.6% |
| WAT | Buy | 25 | 56% | $189.60 | -50.3% |
| ILMN | Hold | 26 | 50% | $169.36 | +41.5% |
| WST | Strong Buy | 23 | 78% | $136.24 | -45.3% |